Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071084
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2003-10-10
Brief Title:
Clinical Trial of HuMax-CD4 a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin
Sponsor:
Genmab
Organization:
Genmab
Organization Data
Organization:
Genmab
Class:
INDUSTRY
Study ID:
Hx-CD4-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genmab
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None